Trefoil Therapeutics presents the proliferation of human corneal endothelia in organ culture stimulated by engineered human fibroblast growth factor 1 (FGF1) derivative TTHX1114
Read MoreTag: ARVO 2020
Filter by:
Search
Year
May 7, 2020
ARVO 2020: Accelerated Healing of Corneal Lesions
Trefoil Therapeutics presents accelerated healing of corneal endothelial lesions by engineered fibroblast growth factor at ARVO 2020.
Read More